Follow on Google News News By Tag * Pharmaceutical * Uzbekistan * Uzpharmsanoat * Security * Equipment * Regime * Neighbouring * Medical * Unrest * Factory * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | "Uzbekistan Pharmaceuticals & Healthcare Report Q1 2011" now available at Fast Market ResearchFast Market Research recommends "Uzbekistan Pharmaceuticals & Healthcare Report Q1 2011" from Business Monitor International, now available
Uzbekistan's pharmaceutical industry has enormous growth potential. Expenditure per capita on medicines was tiny in 2009, at just US$11.3, but the economy and population are growing. However, investors face huge challenges. In recent months - according to media accounts - a court judgment nationalised the Tashkent factory of Russian dairy giant Wimm-Bill-Dann. The Russian company had invested substantially in the once bankrupt facility in recent years, which is now reportedly shuttered for its alleged failure to abide by investment commitments. The company has vowed to pursue the case in the higher courts. We believe that the seizure of a factory belonging to a Russian blue-chip company is a deeply worrying development and reflects the challenges facing even the savviest investors. We also expect the situation to deteriorate as factions jockey for position in anticipation of the eventual departure of President Islam Karimov from the scene. We continue to view Uzbekistan as one of the most challenging places to do business in Central or Eastern Europe (CEE), as reflected in our Business Environment Ratings (BER) for Q111. Investors seeking a manufacturing presence have generally pursued joint venture (JV) deals with domestic manufacturing holding Uzpharmsanoat, which accounts for 90% of production, in order to provide a measure of protection to their investments. For now, the government is committed to attracting outside investment, even as it pursues an explicit import-substitution policy. In a recent speech, President Karimov identified pharmaceuticals as a key sector in the government's industrial development programme for 2011 to 2015 - a programme with a total stated budget of US$40bn. This should ensure continued funding and keep senior officials from meddling in any foreign-owned projects, at least for now. The latest JV deal was announced in October, and involves German investment in a new plant to produce a variety of generic products in the Tashkent region - UzGerMed Pharm. Meanwhile, the largest deal in the pipeline is a Good Manufacturing Practice (GMP)-compliant vaccines factory being built with the participation of Hungary's Omninvest, announced at the beginning of 2010. In July, local media reported that Korean Trust Investment Trading was building a US$4mn pharmaceutical packaging factory as part of a 50-50 joint venture with Uzpharmsanoat, due to open by the end of 2010 in the Navoi Free Industrial-Economic Zone (NFIEZ). Japan's Overseas Medical Equipment Technical Assistance (OMETA) is reportedly eyeing the same region to develop medical equipment production. These companies see the country's almost untapped market potential. It is up to the regime to prove, contrary to recent trends, that it will respect property rights and guarantee that investments representing millions of dollars in FDI will not be squandered. For more information or to purchase this report, go to: - http://www.fastmr.com/ Partial Table of Contents: Executive Summary SWOT Analysis - Uzbekistan Pharmaceuticals And Healthcare Industry SWOT Pharmaceutical Business Environment Ratings - Table: Emerging Europe Pharmaceutical Business Environment Ratings, Q111 - Rewards - Risks Uzbekistan - Market Summary Regulatory Regime - Counterfeit Drugs - Intellectual Property Rights - Pricing and Reimbursement Industry Developments - Epidemiology - Healthcare Sector - Healthcare Sector Reforms - Pharmaceutical Industry - Pharmaceutical Sector Reforms - Pharmaceutical Industry Developments - Pharmaceutical Wholesale and Retail - Research and Development - International Cooperation - Medical Devices Industry Forecast Scenario - Overall Market Forecast - Table: Uzbekistan - Pharmaceutical Market Indicators, Historical Data and Forecasts, 2006-2014 - Key Growth Factors - Industry - Table: Uzbekistan - Healthcare Expenditure Trends, Historical Data and Forecasts, 2006-2014 - Key Growth Factors - Macroeconomic - Table: Uzbekistan - Economic Activity, 2007-2014 - Prescription Drug Market Forecast - Table: Uzbekistan - Prescription Drug Market Indicators, Historical Data and Forecasts, 2006-2014 - Top Ten ATC Level 2 Codes In Uzbekistan By Sales, 2007-2008 - Patented Drug Market Forecast - Table: Uzbekistan - Patented Drug Market Indicators, Historical Data and Forecasts, 2006-2014 - Generic Drug Market Forecast - Table: Uzbekistan - Generics Drug Market Indicators, Historical Data and Forecasts, 2006-2014 - OTC Drug Market Forecast - Table: Uzbekistan - OTC Medicine Market Indicators, Historical Data and Forecasts, 2006-2014 - Pharmaceutical Export/Import Forecast - Table: Uzbekistan - Pharmaceutical Trade Data And Forecasts , 2006-2014 - Other Healthcare Data Forecasts - Key Risks to BMI's Forecasts Competitive Landscape - Table: The Top Ten Drugmakers In Uzbekistan During 2007/08 According To Sales - Table: The Top Ten Trade Names In Uzbekistan During 2007/08 According To Sales - Table: Top 10 INNs and Combinations In Uzbekistan During 2007/2008 According To Sales Company Profiles - Indigenous Companies - Jurabek Laboratories - Uzpharmsanoat - Asklepiy Pharmaceutical Company Full Table of Contents is available at: -- http://www.fastmr.com/ About Business Monitor International Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports. View more research from Business Monitor International at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number